Literature DB >> 15632001

Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis.

Bong-Kyeong Oh1, Young-Joo Kim, Chanil Park, Young Nyun Park.   

Abstract

The telomeric repeat-binding factor 1 (TRF1), TRF2, and the TRF1-interacting nuclear protein 2 (TIN2) are involved in telomere maintenance. We describe the regulation of expression of these genes along with their relationship to telomere length in hepatocarcinogenesis. The transcriptional expression of these genes, TRF1 protein, and telomere length was examined in 9 normal livers, 14 chronic hepatitis, 24 liver cirrhosis, 5 large regenerative nodules, 14 low-grade dysplastic nodules (DNs), 7 high-grade DNs, 10 DNs with hepatocellular carcinoma (HCC) foci, and 31 HCCs. The expression of TRF1, TRF2, TIN2 mRNA, and TRF1 protein was gradually increased according to the progression of hepatocarcinogenesis with a marked increase in high-grade DNs and DNs with HCC foci and a further increase in HCCs. There was a gradual shortening of telomere during hepatocarcinogenesis with a significant reduction in length in DNs. Most nodular lesions (52 of 67) had shorter telomeres than their adjacent chronic hepatitis or liver cirrhosis, and the telomere lengths were inversely correlated with the mRNA level of these genes (P </= 0.001). This was more evident in DNs and DNs with HCC foci. In conclusion, TRF1, TRF2, and TIN2 might be involved in multistep hepatocarcinogenesis by playing crucial roles in telomere shortening.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632001      PMCID: PMC1602303          DOI: 10.1016/S0002-9440(10)62233-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  TIN2, a new regulator of telomere length in human cells.

Authors:  S H Kim; P Kaminker; J Campisi
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  Senescence induced by altered telomere state, not telomere loss.

Authors:  Jan Karlseder; Agata Smogorzewska; Titia de Lange
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

Review 3.  Telomeres, aging and cancer: in search of a happy ending.

Authors:  Sahn-ho Kim Sh; Patrick Kaminker; Judith Campisi
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

Review 4.  Switching and signaling at the telomere.

Authors:  E H Blackburn
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

5.  T-loop assembly in vitro involves binding of TRF2 near the 3' telomeric overhang.

Authors:  R M Stansel; T de Lange; J D Griffith
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

Review 6.  Mammalian telomeres and telomerase.

Authors:  K Collins
Journal:  Curr Opin Cell Biol       Date:  2000-06       Impact factor: 8.382

7.  In situ detection of telomerase enzymatic activity in human hepatocellular carcinogenesis.

Authors:  N Youssef; V Paradis; S Ferlicot; P Bedossa
Journal:  J Pathol       Date:  2001-08       Impact factor: 7.996

8.  Identification of human Rap1: implications for telomere evolution.

Authors:  B Li; S Oestreich; T de Lange
Journal:  Cell       Date:  2000-05-26       Impact factor: 41.582

Review 9.  Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis.

Authors:  Jennifer A Hackett; Carol W Greider
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

10.  The human telomere-associated protein TIN2 stimulates interactions between telomeric DNA tracts in vitro.

Authors:  Sahn-Ho Kim; Seungil Han; Young-Hyun You; David J Chen; Judith Campisi
Journal:  EMBO Rep       Date:  2003-07       Impact factor: 8.807

View more
  53 in total

Review 1.  Telomere biology: Rationale for diagnostics and therapeutics in cancer.

Authors:  Philippe Rousseau; Chantal Autexier
Journal:  RNA Biol       Date:  2015-08-20       Impact factor: 4.652

2.  Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway.

Authors:  Irmina Diala; Nicole Wagner; Frédérique Magdinier; Marina Shkreli; Maria Sirakov; Serge Bauwens; Caroline Schluth-Bolard; Thomas Simonet; Valérie M Renault; Jing Ye; Abdelnnadir Djerbi; Pascal Pineau; Jinkuk Choi; Steven Artandi; Anne Dejean; Michelina Plateroti; Eric Gilson
Journal:  EMBO Rep       Date:  2013-02-22       Impact factor: 8.807

Review 3.  Chronic hepatitis B in hepatocarcinogenesis.

Authors:  N H Park; I H Song; Y-H Chung
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

4.  Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.

Authors:  Neung Hwa Park; Il Han Song; Young-Hwa Chung
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

5.  Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis.

Authors:  D Heim; K Cornils; K Schulze; B Fehse; A W Lohse; T H Brümmendorf; H Wege
Journal:  Oncogene       Date:  2014-01-13       Impact factor: 9.867

6.  Effects of TIN2 on telomeres and chromosomes in the human gastric epithelial cell line GES-1.

Authors:  Fan Fu; Hua Hu; Shuai Yang; Xiaoqiu Liang
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

7.  Gene expression levels of human shelterin complex and shelterin-associated factors regulated by the topoisomerase II inhibitors doxorubicin and etoposide in human cultured cells.

Authors:  Masahiro Kato; Masahiro Nakayama; Minako Agata; Kenichi Yoshida
Journal:  Tumour Biol       Date:  2012-12-18

8.  Clinical significance of telomere length and associated proteins in oral cancer.

Authors:  Rachana N Sainger; Shaila D Telang; Shilin N Shukla; Prabhudas S Patel
Journal:  Biomark Insights       Date:  2007-02-14

9.  A G-quadruplex structure within the 5'-UTR of TRF2 mRNA represses translation in human cells.

Authors:  Dennis Gomez; Aurore Guédin; Jean-Louis Mergny; Bernard Salles; Jean-François Riou; Marie-Paule Teulade-Fichou; Patrick Calsou
Journal:  Nucleic Acids Res       Date:  2010-06-22       Impact factor: 16.971

10.  Moderate expression of TRF2 in the hematopoietic system increases development of large cell blastic T-cell lymphomas.

Authors:  Sebastian Begemann; Francesco Galimi; Jan Karlseder
Journal:  Aging (Albany NY)       Date:  2009-01       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.